The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Carina Biotech
Adelaide, Australia
A
1-10 Employees
2016
Key takeaway
Carina Biotech is at the forefront of developing next-generation CAR-T cell therapies that harness the patient's immune system to combat cancer, offering a promising new treatment option.
Highlighted product
Core business
Carina Biotech | Fighting Cancer with CAR-T Technologies | Australia
Carina Biotech are creating a future that defeats cancer. Empowering patients to fight cancer through next-generation CAR-T therapies. Find out more.
CELL THERAPIES PTY LTD
Melbourne, Australia
A
11-50 Employees
2002
Key takeaway
Cell Therapies is a contract development and manufacturing organization (CDMO) that specializes in the manufacturing and delivery of advanced cell-based therapies, including CAR-T cell therapy. With over 20 years of GMP manufacturing experience and licenses from the Australian Therapeutic Goods Administration, they ensure that their products meet global regulatory standards, offering significant advantages for clinical trial and commercial supply.
Highlighted product
Core business
Cell Therapies | GMP Manufacturing of cell and gene therapies
Groundbreaking cell and gene therapy manufacturing and commercialization cell therapies is an Australian-based, globally-active commercial contract developm ...
Haemalogix
Sydney, Australia
A
1-10 Employees
-
Key takeaway
HaemaLogiX is actively developing CAR-T cell therapies that specifically target unique antigens on malignant bone marrow cells, aiming to improve treatment outcomes for patients with blood cancers like multiple myeloma. Their team's expertise in immunotherapy and monoclonal antibodies underpins this innovative approach to combating hematological malignancies.
Highlighted product
Product
Technology | HaemaLogiX
Following the discovery of two unique antigens on malignant Bone Marrow Cells, HaemaLogiX is developing Monoclonal Antibodies, CAR T cell Therapies and Bispecific Antibodies that specifically target those malignant cells.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Myrio Tx
Melbourne, Australia
A
11-50 Employees
2009
Key takeaway
Myrio Therapeutics is focused on developing innovative antibody-based therapies that target proteins inside cells, including those associated with cancer. Their advanced antibody discovery platform, Retained DisplayTM (ReD), positions them at the forefront of immuno-oncology.
Highlighted product
Core business
About Us - Myrio Tx
EnGeneIC
Sydney, Australia
A
11-50 Employees
2000
Key takeaway
EnGeneIC is actively engaged in the research and development of targeted anti-cancer therapies, having received FDA "Fast-Track" designation for its pancreatic cancer treatment. Their innovative approach involves using bispecific antibody-targeted EDV™ nanocells that effectively target tumor cells by leveraging the unique characteristics of tumor vasculature.
Highlighted product
Product
Targeting Tumors Cells - EnGeneIC
Targeting Tumor CellsThe tumor cell-surface receptor being targeted does not need to be unique to tumor cells since the bispecific antibody-targeted, payload-packaged EDV™ nanocells only exit the leaky blood vessels associated with tumors (passive targeting) and enter the tumor microenvironment. The EDV™ is 400nm ± 20nm which is too large to escape through the normal … Continue reading →
Cartago Biotech Pty Ltd
Sydney, Australia
A
1-10 Employees
2020
Key takeaway
Cartago Biotech is focused on innovative approaches in tissue regeneration, which may have implications for enhancing the quality of life for patients with chronic conditions.
Highlighted product
Product
Cartago Biotech Pty Ltd - Chronic Back Pain, Tissue Regeneration
Better quality of life
TGR BioSciences
Adelaide, Australia
A
11-50 Employees
2001
Key takeaway
TGR BioSciences specializes in innovative solutions for cell-based research applications, making it relevant for advancements in therapies like CAR-T cell therapy. Their patented CaptSure™ technology enhances the performance and efficiency of immunoassays, which could be instrumental in the research and development of cell therapies.
Highlighted product
Core business
TGR BioSciences
Prorenata Biotech
Gold Coast City, Australia
A
1-10 Employees
2021
Key takeaway
Prorenata Biotech specializes in genetic medicine and innovative approaches like CRISPR and Lipid Nanoparticles, aiming to accelerate the development of gene-based therapeutics and vaccines. Their mission focuses on making advanced treatments more accessible to researchers and healthcare providers, ultimately benefiting those with unmet health needs.
Highlighted product
Core business
Nanomedicine - LNPs & Genetic Medicine - Prorenata Biotech
We are experts in Lipid Nanoparticles and Gene Editing using CRISPR. We will ensure your molecule reaches its full potential!
CRAIG CARDEN
Ballarat, Australia
A
1-10 Employees
2010
Key takeaway
The company, Ballarat Cancer Care, specializes in providing comprehensive, evidence-based care for patients with blood cancer and disorders, emphasizing personalized treatment and a dedicated team of oncologists and haematologists.
Highlighted product
Service
Services - Ballarat Cancer Care and Haematology
At Ballarat Cancer Care, we are focussed on building a dedicated and exciting group of Oncologists and Haematologists committed to looking after patients with cancer and blood disorders.
AUCENTRA THERAPEUTICS PTY LTD
Adelaide, Australia
A
11-50 Employees
-
Key takeaway
Aucentra Therapeutics is focused on developing innovative anti-cancer drugs, with a strong pipeline that includes candidates for treating leukemia and other aggressive cancers. Their expertise in small molecule drug discovery positions them to address significant unmet medical needs in cancer treatment.
Highlighted product
Core business
Aucentra | Cancer Therapeutics
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T cell therapy industry in Australia, several key considerations emerge. Firstly, regulatory compliance is crucial, as the Therapeutic Goods Administration (TGA) governs the approval and monitoring of cellular therapies. Understanding the clinical trial landscape is also essential, as advancements in CAR-T therapies often stem from successful trials that address specific hematological malignancies. The competitive landscape features both established pharmaceutical companies and innovative biotech firms, necessitating thorough research on their pipelines and partnerships. Moreover, the challenges of high treatment costs and access to therapies can impact market dynamics and patient outcomes. Opportunities exist for collaboration between research institutions and industry players, particularly in developing next-generation therapies with improved efficacy and safety profiles. Environmental concerns related to the manufacturing processes and waste management in the biotech sector are increasingly relevant, prompting companies to adopt sustainable practices. Additionally, the global market relevance of CAR-T therapies highlights Australia's potential role as a research and development hub, contributing to global advancements in this field. Overall, a comprehensive understanding of these factors will provide valuable insights for anyone interested in the CAR-T cell therapy industry in Australia.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Australia |
| Amount of fitting manufacturers | 98 |
| Amount of suitable service providers | 98 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2000 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CAR-T Cell Therapy?
Start-Ups who are working in CAR-T Cell Therapy are Cartago Biotech Pty Ltd, Prorenata Biotech
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are Biotechnology, Other, IT, Software and Services, Healthcare, Medical
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
